Clinical Trials Directory

Trials / Sponsors / HemaQuest Pharmaceuticals Inc.

HemaQuest Pharmaceuticals Inc.

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
TerminatedEffects of HQK-1001 in Patients With Sickle Cell Disease
Sickle Cell Disease, Sickle Cell Anemia, Sickle Cell Disorders
Phase 22012-07-01
CompletedA Study of HQK-1001 in Patients With Sickle Cell Disease
Sickle Cell Disease, Sickle Cell Anemia, Sickle Cell Disorders
Phase 22011-04-01
TerminatedStudy of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lym
Lymphoid Malignancies, Lymphoproliferative Disorders
Phase 22010-05-01
CompletedPhase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia
Beta Thalassemia
Phase 1 / Phase 22009-03-01
CompletedPhase 1/2 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK-1001 Administered Daily in Pa
Sickle Cell Disease
Phase 1 / Phase 22009-03-01
TerminatedStudy of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
EBV Lymphomas, Lympho-proliferative Diseases
Phase 22008-09-01
CompletedPhase 1 Placebo Controlled Study of the Safety, Activity and Pharmacokinetics of HQK-1001 in Healthy Subjects
Healthy
Phase 12008-05-01
CompletedA Phase 1, Single-Dose Safety and Pharmacokinetic Study of Sodium ST20 in Healthy Volunteers
Healthy
Phase 12008-01-01